Psychiatry · South Miami, FL
NPI
1700224896
Since 2013
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7031 SW 62nd Ave
South Miami, FL, 33143
Phone (305) 284-7575
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
16,611 prescriptions
Company payments, 2025
$1,414
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Rafael A Garcia prescribed most often to Medicare patients was Clonazepam, with 1,213 prescriptions and refills. In total Rafael A Garcia wrote 16,611 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clonazepam Generic | 1,213 | 1,221 | 141 | $5,531 |
| Escitalopram Oxalate Generic | 984 | 1,088 | 133 | $3,632 |
| Fluoxetine Hcl Generic | 884 | 938 | 94 | $2,887 |
| Trazodone Hcl Generic | 869 | 908 | 113 | $2,853 |
| Gabapentin Generic | 864 | 911 | 127 | $4,771 |
| Quetiapine Fumarate Generic | 856 | 882 | 106 | $11K |
| Mirtazapine Generic | 638 | 693 | 87 | $5,508 |
| Buspirone Hcl Generic | 587 | 642 | 84 | $4,484 |
| Sertraline Hcl Generic | 571 | 654 | 74 | $2,043 |
| Aripiprazole Generic | 539 | 578 | 62 | $60K |
| Temazepam Generic | 502 | 507 | 61 | $4,437 |
| Donepezil Hcl Generic | 489 | 530 | 86 | $1,495 |
| Risperidone Generic | 433 | 461 | 53 | $3,211 |
| Hydroxyzine Pamoate Generic | 369 | 384 | 50 | $1,659 |
| Lorazepam Generic | 341 | 342 | 44 | $1,357 |
Brand drugs: 884 claims; generic drugs: 15,727 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael A Garcia $1,414 ($1,414 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $480.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $480 |
| Alkermes, Inc. ALKS | 10 | $203 |
| Axsome Therapeutics, Inc. AXSM | 6 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $148 |
| Lundbeck LLC | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $102 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $75.37 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $72.26 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $47.33 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $24.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.